Walker & Dunlop, Inc., through its subsidiaries, originates, sells, and services a range of multifamily and other commercial real estate financing products and services for owners and developers of real estate in the United States. The company offers first mortgage, second trust, supplemental, construction, mezzanine, preferred equity, small-balance, and bridge/interim loans. It also provides multifamily finance for manufactured housing communities, student housing, affordable housing, and senior housing properties under the Fannie Mae's DUS program; and construction and permanent loans to developers and owners of multifamily housing, affordable housing, senior housing, and healthcare facilities. In addition, the company acts as an intermediary in the placement of commercial real estate debt between institutional sources of capital, including life insurance companies, investment banks, commercial banks, pension funds, CMBS conduits, and other institutional investors, as well as owners of various types of commercial real estate. Further, it advises on capital structure; develops the financing package; facilitates negotiations between its client and institutional sources of capital; coordinates due diligence; and assists in closing the transaction. Additionally, the company offers property sales brokerage, underwriting and risk management, and servicing and asset management services. Walker & Dunlop, Inc. was founded in 1937 and is headquartered in Bethesda, Maryland.
IPO Year: 2010
Exchange: NYSE
Website: walkerdunlop.com
| Date | Price Target | Rating | Analyst |
|---|---|---|---|
| 3/6/2025 | $105.00 | Mkt Perform → Outperform | Keefe Bruyette |
| 4/11/2024 | $130.00 → $95.00 | Outperform → Neutral | Wedbush |
| 12/13/2023 | $85.00 → $105.00 | Outperform → Mkt Perform | Keefe Bruyette |
| 12/11/2023 | $90.00 → $110.00 | Outperform | Wedbush |
| 5/2/2023 | Mkt Outperform → Mkt Perform | JMP Securities | |
| 2/1/2023 | Outperform → Peer Perform | Wolfe Research | |
| 3/10/2022 | $191.00 → $183.00 | Outperform | Wolfe Research |
| 1/21/2022 | Mkt Perform → Outperform | Keefe Bruyette | |
| 11/8/2021 | $190.00 | Buy | Jefferies |
| 10/7/2021 | $130.00 → $140.00 | Market Outperform | JMP Securities |
SCHEDULE 13G/A - Walker & Dunlop, Inc. (0001497770) (Subject)
10-Q - Walker & Dunlop, Inc. (0001497770) (Filer)
8-K - Walker & Dunlop, Inc. (0001497770) (Filer)
8-K - Walker & Dunlop, Inc. (0001497770) (Filer)
8-K - Walker & Dunlop, Inc. (0001497770) (Filer)
8-K - Walker & Dunlop, Inc. (0001497770) (Filer)
DEFA14A - Walker & Dunlop, Inc. (0001497770) (Filer)
DEF 14A - Walker & Dunlop, Inc. (0001497770) (Filer)
8-K - Walker & Dunlop, Inc. (0001497770) (Filer)
8-K - Walker & Dunlop, Inc. (0001497770) (Filer)
4 - Walker & Dunlop, Inc. (0001497770) (Issuer)
Keefe Bruyette upgraded Walker & Dunlop from Mkt Perform to Outperform and set a new price target of $105.00
Wedbush downgraded Walker & Dunlop from Outperform to Neutral and set a new price target of $95.00 from $130.00 previously
Keefe Bruyette downgraded Walker & Dunlop from Outperform to Mkt Perform and set a new price target of $105.00 from $85.00 previously
Wedbush reiterated coverage of Walker & Dunlop with a rating of Outperform and set a new price target of $110.00 from $90.00 previously
JMP Securities downgraded Walker & Dunlop from Mkt Outperform to Mkt Perform
Wolfe Research downgraded Walker & Dunlop from Outperform to Peer Perform
Wolfe Research reiterated coverage of Walker & Dunlop with a rating of Outperform and set a new price target of $183.00 from $191.00 previously
Keefe Bruyette upgraded Walker & Dunlop from Mkt Perform to Outperform
Jefferies initiated coverage of Walker & Dunlop with a rating of Buy and set a new price target of $190.00
JMP Securities reiterated coverage of Walker & Dunlop with a rating of Market Outperform and set a new price target of $140.00 from $130.00 previously